Systemic bevacizumab leads to resolution of diabetic macular edema.
OBJECTIVE
The purpose of this study is to report a case of diabetic macular edema that resolved after systemic bevacizumab.


METHODS
This is an observational case report of a patient with diabetic macular edema.


RESULTS
After initiation of systemic bevacizumab for a central nervous system glioblastoma, the diabetic macular edema resolved.


CONCLUSIONS
Systemic bevacizumab may result in the resolution of macular edema secondary to diabetes.
From the Vitreoretinal Service, Duke Eye Center, Duke University Medical Center, Durham, North Carolina.
Justis P
JP
Ehlers
Sharon
S
Fekrat